Abstract Submission is Open

Submit your abstract for ARVO 2019 by November 30.
IOVS Special issue
View a special issue of IOVS journal on Dry Age-Related Macular Degeneration
Global mentorship
Global mentors and mentees talk relationship building
Traveling to ARVO 2019
Helpful tips for your trip to Vancouver
Join us in Vancouver
Register early for ARVO 2019 and save

ARVO members among 2018 Champalimaud Vision Award winners

Seven scientists were recognized for their extraordinary scientific advances which led to the successful treatment of a genetic cause of childhood blindness, a version of Leber Congenital Amaurosis, and demonstrated the potential for future developments in gene therapy to cure other inherited diseases.
Renew your membership
Now is the time to renew your ARVO membership for 2019
Find funding
Search through our enhanced Funding Guide with 200+ opportunities
Publications grant
Apply for ARVO’s Publications Grant, available to authors who need funding assistance to publish in one of our three journals

Apply for the Women's Leadership Development Program

We are seeking mentor and mentee applicants for the 2019 - 2020 program year. The program provides emerging women leaders within the ARVO membership a highly interactive, year-long learning experience focused on developing leadership skills and facilitating leadership opportunities and networking. Deadline to apply is Oct. 31.

Upcoming Events

Abstract submission is open

Note that the deadline to submit an abstract for the ARVO 2019 Annual Meeting in Vancouver is Nov. 30, 2018.

ARVO key dates and deadlines

View a monthly listing of key dates and deadlines for the Eye and Vision Science Community

Plan your stay at ARVO 2019

Book your hotel room now and get the best selection for ARVO 2019 in Vancouver, Canada, April 28 - May 2

Latest news

Visit our Press Room to see the latest eye and vision research news and view ARVO press releases.

Telling the story of OCT

Optical coherence tomography (OCT) is a technology invented by ARVO members that helps preserve patients' sight, saves taxpayers billions of dollars and enables further discoveries in science and medicine. See how ARVO has shared the impact of OCT with vision scientists, patients, and policymakers.